Pan Chen
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Biological Psychiatry top 10%
Papers in
-
- RNA modifications and cancer 7
- Natural product bioactivities and synthesis 6
-
- Cancer-related molecular mechanisms research 11
- MicroRNA in disease regulation 7
- Co-authors
- Guiyuan Li (11 shared papers)Wei Xiong (7 shared papers)Wenling Zhang (9 shared papers)Xiayu Li (10 shared papers)Qianjin Liao (8 shared papers)Peibo Li (12 shared papers)Xiaoling Li (6 shared papers)Zhaoyang Zeng (9 shared papers)
- Journals
- Journal of Cancer (3 papers)Bioorganic Chemistry (3 papers)Frontiers in Immunology (2 papers)Molecules (2 papers)British Journal of Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Pan Chen
79 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 132
- Cancer Research 405
- Biological Psychiatry 43
- Pharmacology 113
- Molecular Biology 750
- Health, Toxicology and Mutagenesis 101
Countries citing papers authored by Pan Chen
This map shows the geographic impact of Pan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pan Chen more than expected).
Fields of papers citing papers by Pan Chen
This network shows the impact of papers produced by Pan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pan Chen. The network helps show where Pan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Pan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 80 | |
| 2 | 2017 | 65 | |
| 3 | 2013 | 65 | |
| 4 | 2011 | 62 | |
| 5 | 2015 | 59 | |
| 6 | 2011 | 59 | |
| 7 | 2011 | 57 | |
| 8 | 2022 | 57 | |
| 9 | 2018 | 50 | |
| 10 | 2016 | 47 | |
| 11 | 2020 | 41 | |
| 12 | 2017 | 36 | |
| 13 | 2019 | 35 | |
| 14 | 2024 | 34 | |
| 15 | 2016 | 31 | |
| 16 | 2019 | 27 | |
| 17 | 2013 | 27 | |
| 18 | 2015 | 27 | |
| 19 | 2019 | 26 | |
| 20 | 2017 | 24 |
About Pan Chen
Pan Chen is a scholar working on Molecular Biology, Cancer Research, Physiology, Immunology and Plant Science, having authored 82 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (7 papers), MicroRNA in disease regulation (7 papers), Natural product bioactivities and synthesis (6 papers), Tryptophan and brain disorders (5 papers), Effects and risks of endocrine disrupting chemicals (5 papers), Oral Health Pathology and Treatment (4 papers) and Phytochemistry and Biological Activities (4 papers). The work is most often cited by research in Cancer Research (405 citations), Biological Psychiatry (43 citations), Pharmacology (113 citations), Molecular Biology (750 citations) and Health, Toxicology and Mutagenesis (101 citations). Pan Chen has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Guiyuan Li, Wei Xiong, Wenling Zhang, Xiayu Li, Qianjin Liao, Peibo Li, Xiaoling Li, Zhaoyang Zeng, Yonggang Wang and Lichun Xu. Their work appears in journals such as Journal of Cancer, Bioorganic Chemistry, Frontiers in Immunology, Molecules and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.